Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction-Reference-Cited by-同舟云学术

Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction

Published:1991-11 Issue:8 Volume:6 Page:484-486
ISSN:0885-3924
Container-title:Journal of Pain and Symptom Management
language:en
Short-container-title:Journal of Pain and Symptom Management

Author:

De Conno Franco,Caraceni Augusto,Zecca Ernesto,Spoldi Elio,Ventafridda Vittorio

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),General Nursing

Reference10 articles.

1. Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and patholological study;Baines;Lancet,1985

2. The use of the syringe driver in terminal care;Oliver;Br J Clin Pharmacol,1985

3. The management of inoperable gastrointestinal obstruction in terminal cancer patients;Ventafridda;Tumori,1990

4. Uber Wirkungsunterchiede von Atropin, Scopolamin und einigen ihren quartaren Derivate nach subcutaner und enteralen Gabe unter besonderer Berucksichtigung des Scopolamin-n-butylbromids;Bauer;Arzneimittel Forschung,1968

5. Atropine, scopolamine and related antimuscarinic drugs;Weiner,1980

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abdomen and pelvis: Symptoms and toxicities;Palliative Radiation Oncology;2024

2. Subcutaneous drug supply in the practice of a primary care physician – a literature review;Family Medicine & Primary Care Review;2023

3. Inoperable Bowel Obstruction in Ovarian Cancer: Prevalence, Impact and Management Challenges;International Journal of Women's Health;2022-12

4. Nausea and vomiting in palliative care;Medicine;2022-12

5. MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer;Supportive Care in Cancer;2022-03-10